戻る
Guangzhou Innogen Pharmaceutical Group Co., Ltd (02591.HK)価格
02591.HK 株価推移チャート
INNOGEN-B (02591.HK)
Guangzhou Innogen Pharmaceutical Group Co., Ltd
HK$30.98
-3.18%
$-1.01
休場: Jan 16, 16:00:00 HKT
主要データ
前終値
$31.02
始値
$32
当日レンジ
$30.86 - $32.78
52週レンジ
$28.4 - $74
取引高
410.8K
平均取引高
667.1K
1株当たり利益(TTM)
-0.54
配当利回り
--
時価総額
$13.0B
INNOGEN-Bとは何ですか？
Guangzhou Innogen Pharmaceutical Group Co., Ltd. engages in the production and distribution of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 105 full-time employees. The company went IPO on 2025-08-15. The firm is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The firm is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The firm principally conducts its businesses in the domestic market.